Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Consolidated Net Income: 2010-2012

Historic Consolidated Net Income for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$954,000.

  • Sonoma Pharmaceuticals' Consolidated Net Income rose 63.49% to -$954,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.6 million, marking a year-over-year increase of 36.33%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' Consolidated Net Income stood at -$954,000, which was up 12.96% from -$1.1 million recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Consolidated Net Income high stood at -$782,000 for Q2 2012, and its period low was -$2.6 million during Q4 2011.
  • Its 3-year average for Consolidated Net Income is -$1.6 million, with a median of -$1.7 million in 2010.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Consolidated Net Income in the last 5 years was 64.11% (2012), contrasted with its biggest fall of 27.59% (2012).
  • Over the past 3 years, Sonoma Pharmaceuticals' Consolidated Net Income (Quarterly) stood at -$2.2 million in 2010, then dropped by 19.59% to -$2.6 million in 2011, then surged by 63.49% to -$954,000 in 2012.
  • Its Consolidated Net Income was -$954,000 in Q4 2012, compared to -$1.1 million in Q3 2012 and -$782,000 in Q2 2012.